The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021.
Journal
Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
accepted:
22
12
2021
pubmed:
29
1
2022
medline:
6
4
2022
entrez:
28
1
2022
Statut:
ppublish
Résumé
Medication-related problems often lead to patient harm. This paper aims to review the Australian literature to determine the overall incidence, severity and preventability of medication-related hospital admissions, as well as providing a national estimate on their extent and cost. The first part of the paper includes a literature search to identify studies that provided estimates of medication-related problems that caused hospital admissions. Incidence of medication-related hospital admissions, type of medication-related problem contributing to admission (e.g. adverse medicine reaction) and method used to estimate incidence (e.g. chart review) were extracted. Data on severity and preventability of the admissions were extracted where available. The second part of the paper involves use of methodological triangulation to estimate the extent and cost of medication-related hospital admission. Median estimates used to assess medication-related hospital admissions and the 2019-2020 national hospital admissions data were used to calculate the national estimate on the extent of medication-related hospital admission. Costs were also estimated. Seventeen studies provided estimates on the extent of medication-related hospital admissions as assessed using medication chart review. The median incidence of 2.5% (interquartile range [IQR] 0.6%) as a proportion of all hospital admissions suggests 275,000 hospital admissions annually in Australia are medication related. The median incidence of 9% (IQR 3.9%) of emergency admissions suggests that 270,000 admissions annually are medication related. Eight studies provided estimates of the extent of medication-related hospital admissions identified from administrative health data; the median incidence of 1.7% with an under-reporting rate of 82% suggests 280,000 hospital admissions annually are medication related. Triangulation of results suggests that at least 250,000 hospital admissions annually in Australia are medication related, with an estimated cost of 1.4 billion Australian dollars (AUD$). Five studies assessed severity, and nine studies assessed preventability. Preventability estimates suggest two-thirds of medication-related hospital admissions are potentially preventable. We estimated that 250,000 hospital admissions in Australia are medication related, with an annual cost of AUD$1.4 billion to the healthcare system. Two-thirds of medication-related hospital admissions are potentially preventable.
Identifiants
pubmed: 35089582
doi: 10.1007/s40264-021-01144-1
pii: 10.1007/s40264-021-01144-1
pmc: PMC8933367
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
249-257Informations de copyright
© 2022. The Author(s).
Références
Australian Institute of Health and Welfare. Medicines in the health system. 2020. https://www.aihw.gov.au/reports/australias-health/medicines-in-the-health-system . Cited 6 Oct 2021.
Australian Bureau of Statistics. National Health Survey: Persons accessing Pharmaceutical Benefits Scheme subsidised prescriptions, 2014-15. 2020. https://www.abs.gov.au/statistics/research/national-health-survey-persons-accessing-pharmaceutical-benefits-scheme-subsidised-prescriptions-2014-15 . Cited 6 Oct 2021.
Australian Institute of Health and Welfare. Health expenditure Australia 2018–2019. 2020. https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2018-19/contents/data-visualisation . Cited 6 Oct 2021.
Strand LM, et al. Drug-related problems: their structure and function. DICP. 1990;24(11):1093–7.
doi: 10.1177/106002809002401114
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9.
doi: 10.1016/S0140-6736(00)02799-9
Pharmaceutical Society of Australia. Medicine safety: take care. 2019. https://www.psa.org.au/wp-content/uploads/2019/01/PSA-Medicine-Safety-Report.pdf . Cited 28 Oct 2019
Pharmacy Programs Administrator. Home medicines review. 2018. https://www.ppaonline.com.au/programs/medication-management-programs/home-medicines-review . Cited 30 Aug 2021
de Vries EN, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216–23.
doi: 10.1136/qshc.2007.023622
Kapoor A, et al. Adverse events in long-term care residents transitioning from hospital back to nursing home. JAMA Intern Med. 2019;179(9):1254–61.
doi: 10.1001/jamainternmed.2019.2005
Australian Council on Safety and Quality in Health Care, Second national report on improving patient safety: improving medication safety. 2002, Australian Council on Safety and Quality in Health Care: Canberra.
Roughead E, Semple S. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Aust N Zeal Health Policy. 2009;6(1):18.
doi: 10.1186/1743-8462-6-18
Roughead L, Semple S, Rosenfeld E. Literature Review: Medication Safety in Australia. 2013. https://www.safetyandquality.gov.au/sites/default/files/migrated/Literature-Review-Medication-Safety-in-Australia-2013.pdf . Cited 28 Oct 2019
Australian Institute of Health and Welfare. Admitted patients. 2021. https://www.aihw.gov.au/reports-data/myhospitals/sectors/admitted-patients . Cited 12 Oct 2021
Denzin NK. The research act: a theoretical introduction to sociological methods. New Jersey: Transaction Publishers; 1970.
Australian Institute of Health and Welfare. Spending on admitted patients. 2019. https://www.aihw.gov.au/reports-data/myhospitals/intersection/spending/apc . Cited 12 Oct 2021
Tukey JW. Exploratory data analysis. Vol 2. Reading, Mass; 1977.
Gleeson CA. Adverse drug reactions causing hospital admissions. Sydney: University of Sydney; 1988.
Larmour I, et al. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm. 1991;21:90–5.
Galbraith K. Is there a role for a clinical pharmacist in the emergency department? In: Victorian College of Pharmacy. 1993, Monash University: Melbourne.
Dartnell JG, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust. 1996;164(11):659–62.
doi: 10.5694/j.1326-5377.1996.tb122235.x
Phillips AL, et al. Hospital admissions caused by adverse drug events: an Australian prospective study. Aust Health Rev. 2014;38(1):51–7.
doi: 10.1071/AH12027
Li R et al. (2021) Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Expert Opin Drug Saf. 2021: 1–8
Sarkawai H, Daud TM A study of drug induced illness as a contributor to hospital admissions. Royal Adelaide Hospital: Adelaide; 1995.
Stanton LA, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther. 1994;19(6):341–7.
doi: 10.1111/j.1365-2710.1994.tb00691.x
Leishman S, Vial JH. Drug related admissions to the Royal Hobart Hospital. in Australian Society of Clinical and Experimental Pharmacology (ASCEPT). 1998. ASCEPT.
Wong ME, et al. Drug-related hospital admissions of geriatric patients. Aust J Hosp Pharm. 1993;23:75.
Parameswaran Nair N, et al. Adverse drug reaction-related hospitalizations in elderly australians: a prospective cross-sectional study in two tasmanian hospitals. Drug Saf. 2017;40(7):597–606.
doi: 10.1007/s40264-017-0528-z
Harding AM. A snapshot of admissions to an acute medical unit for the aged. Aust J Hosp Pharm. 1998;28:359–60.
doi: 10.1002/jppr1998285359
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199–205.
doi: 10.1046/j.1445-5994.2001.00044.x
Atkin PA, et al. Prevalence of drug-related admissions to a hospital geriatric service. Aust J Ageing. 1994;13:17–21.
doi: 10.1111/j.1741-6612.1994.tb00627.x
Ng D. Adverse medication-related events and unplanned admissions to an acute care general teaching hospital. Adelaide: University of South Australia; 1996.
Easton KL, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust. 1998;169(7):356–9.
doi: 10.5694/j.1326-5377.1998.tb126802.x
Easton KL, Chapman CB, Brien JA. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol. 2004;57(5):611–5.
doi: 10.1111/j.1365-2125.2003.02052.x
Roughead E, et al. Coding drug-related admissions in medical records: is it adequate for monitoring the quality of medication use? Aust J Hosp Pharm. 1998;28(1):7–12.
doi: 10.1002/jppr19982817
Carroll R, McLean J, Walsh M. Reporting hospital adverse events using the Alfred Hospital’s morbidity data. Aust Health Rev. 2003;26(2):100–5.
doi: 10.1071/AH030100
Hodgkinson MR, Dirnbauer NJ, Larmour I. Identification of adverse drug reactions using the ICD-10 Australian modification clinical coding surveillance. J Pharm Pract Res. 2009;39(1):19–23.
doi: 10.1002/j.2055-2335.2009.tb00698.x
Hauck K, Zhao X. How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients. Med Care. 2011;49(12):1068–75.
doi: 10.1097/MLR.0b013e31822efb09
Claydon-Platt K, Manias E, Dunning T. Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract. 2012;97(2):223–30.
doi: 10.1016/j.diabres.2012.03.003
Du W et al. Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: application to an Australia population-based study. Public Health Res Pract. 2017. 27(2)
Parameswaran Nair N, et al. Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: a comparative analysis. Pharmacoepidemiol Drug Saf. 2018;27(11):1281–5.
doi: 10.1002/pds.4667
Mullan J, et al. Hospitalisation for medication misadventures among older adults with and without dementia: a 5-year retrospective study. Aust J Ageing. 2019;38(4):e135–41.
doi: 10.1111/ajag.12712
Schumock G, Thornton J. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538–538.
pubmed: 10118597
Hallas J, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.
doi: 10.1111/j.1365-2796.1990.tb00199.x
Slight SP, et al. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. J Am Med Inform Assoc. 2018;25(9):1183–8.
doi: 10.1093/jamia/ocy066
Leendertse AJ, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health. 2011;14(1):34–40.
doi: 10.1016/j.jval.2010.10.024
Parameswaran Nair N, et al. Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the royal Hobart hospital. Drugs Aging. 2017;34(10):777–83.
doi: 10.1007/s40266-017-0490-6
Australian Government Department of Health. Medical research future fund. 2021. https://www.health.gov.au/initiatives-and-programs/medical-research-future-fund . Cited 20 Oct 2021